Table 3 Oncologic results
Variable | Number (%) or Mean (Min-Max) | ||
|---|---|---|---|
RNU (N = 31) | ONU (N = 29) | P Value | |
Pathologic stages | |||
T1 | 16(51.6) | 13 (44.8) | 0.951 |
T2 | 10 (32.3) | 12 (41.4) | |
T3 | 4 (12.9) | 4 (13.8) | |
T4 | 1 (3.2) | 0 (0.0) | |
Grade | |||
Low | 18 (58.1) | 10 (34.5) | 0.077 |
High | 13 (41.9) | 19 (65.5) | |
Node | 20 (64.5) | 9 (31.0) | |
Negative | 19 (95) | 6 (66.7) | 0.076 |
Positive | 1 (5) | 3 (33.3) | |
Recurrence | 11 (35.4) | 14 (48.2) | 0.300 |
Bladder | 9 (29.0) | 13 (44.8) | 0.285 |
Local | 2 (6.4) | 1 (3.4) | |
Metastasis | 3 (9.7) | 2 (6.9) | 1.000 |
Follow up time (months) | 26.4 (3–72) | 27.9 (3–63) | 0.534 |
2 yr. disease specific survival | 86.3% | 92.5% | 0.8227 |
2 yr. overall survival | 86.3% | 83.3% | 0.8628 |